Business Context and Reporting Period
This Form 6-K filing by Guardforce AI Co., Ltd. covers the month of April 2022, specifically reporting on a material definitive agreement entered into on April 6, 2022. The company, a foreign private issuer based in Singapore, announced a registered direct offering of ordinary shares.
Key Financial Metrics
- Gross Proceeds: Approximately $10.05 million from the sale of 8,739,351 ordinary shares.
- Net Proceeds: Approximately $9.17 million after deducting placement agent fees and expenses.
- Placement Fees: 7.5% of gross proceeds plus 0.5% for non-accountable expenses, with up to $70,000 reimbursable for accountable expenses.
- Debt and Liquidity: The filing does not provide specific data on existing debt levels, cash flow, or liquidity ratios outside of the new financing proceeds.
Material Changes
The primary material change is the completion of a registered direct offering. Additionally, due to antidilution provisions in existing warrants, the exercise price for both Public Warrants (from the September 2021 offering) and Private Warrants (from the January 2022 private placement) was adjusted downward from $1.30 to $1.15 per share.
Guidance, Outlook, and Risks
- Use of Proceeds: Net cash proceeds are intended for acquisitions, partnerships, technology investments, corporate infrastructure expansion, sales team expansion, marketing efforts, and general working capital.
- Lock-Up Agreements: The Company, certain officers, directors, and shareholders owning 6% or more have agreed to a 45-day lock-up period following the closing of the financing.
- Issuance Restriction: The Company agreed not to issue additional ordinary shares or equivalents for 45 days post-closing, subject to exceptions.
- Risk Disclosure: The filing explicitly states that representations and warranties in the Purchase Agreement are for risk allocation between parties and should not be relied upon as factual characterizations of the Company's condition.
Investor Verification Checklist
- Verify the final closing date of the financing, expected on or about April 8, 2022.
- Confirm the adjusted exercise price of $1.15 for outstanding Public and Private Warrants.
- Review the attached Securities Purchase Agreement (Exhibit 10.1) for specific covenants and exceptions to the lock-up and issuance restrictions.
- Monitor future filings for the actual deployment of the $9.17 million in net proceeds.